Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts1. The company focuses on RNA therapeutics, primarily mRNA vaccines1. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response1.
Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients2. The company’s only commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax1. The company has 45 treatment and vaccine candidates, of which 38 have entered clinical trials1.
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan1. Stéphane Bancel, the current CEO, was appointed as CEO in 20111.
Moderna: Products
Moderna is a company that operates in two distinct sectors:
- Pet Products: Moderna aims to be a global leader in creating, producing, and distributing well-designed smart plastics for the pet industry1.
- mRNA Medicines: Moderna is pioneering mRNA technology to create a new generation of transformative medicines for patients. They have 48 products in the pipeline and 35 ongoing clinical trials2. You can track the development of Moderna’s mRNA medicines from preclinical development to the commercial phase on their website3.
Moderna: History
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines1. The company’s name is derived from the terms “modified”, “RNA”, and "modern"1.
Here is a brief history of Moderna:
- 2010: Moderna was founded by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan1.
- 2011: Stéphane Bancel, the current CEO, was appointed1.
- 2013: The company formed a partnership with AstraZeneca to develop treatments for cardiovascular, metabolic, and renal diseases, as well as cancer1.
- 2014: The company entered an agreement with Alexion Pharmaceuticals to develop treatments against ten diseases1.
- Moderna begins research into the production of mRNA medicines2.
- Moderna initiates first-in-human dose of an mRNA vaccine (mRNA-1440), an H10N8 flu vaccine candidate2.
- Lease signed to build 200,000 sq ft GMP mRNA clinical manufacturing facility in Norwood, MA2.
- Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease – human metapneumovirus (hMPV virus) and parainfluenza virus2.
- Moderna announces dosing of the first antibody encoded by mRNA in a clinical trial2.
- The U.S. Centers for Disease Control and Prevention votes to recommend the use of the Moderna COVID-19 vaccine in people 18 years of age and older in the U.S2.
- The U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older in the U.S2.
For more detailed information, you can visit the official Moderna website2 or their Wikipedia page1.
Moderna: Competitors
Moderna, a biotechnology company that develops therapeutics and vaccines, has several competitors in the field. Here are some of them:
- CureVac: A biotechnology company offering messenger RNA (mRNA) technology1.
- Regulus Therapeutics: A biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs1.
- Alnylam Pharmaceuticals: A biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi1.
- Celyad: A biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology1.
- Sarepta Therapeutics: A biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases1.
Other competitors include Kite Pharma, Adaptive Biotechnologies, Horizon Therapeutics, Spark Therapeutics, and Incyte2. Some of the top competitors also include Pfizer, AstraZeneca, and eTheRNA3.
Moderna: CEO
The CEO of Moderna is Stéphane Bancel1. He has been the CEO since 20112. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux1. He is known for leading Moderna in the development of its COVID-19 vaccine1. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna1.
If you liked the post, please support me by subscribing, liking, and commenting, it will help me make more posts. ^^
" This material is for informational purposes only. We cannot guarantee the accuracy or completeness of the content, so please use it as a reference only. This material may not be used as evidence of legal liability under any circumstances. "
2023.12.14 - [Introduce and analyze companies] - What is AMD? - Products and History
What is AMD? - Products and History
Advanced Micro Devices, Inc. (AMD) is an American multinational semiconductor company based in Santa Clara, California1. The company was founded in 1969 by Jerry Sanders and a group of other technology professionals1. AMD develops computer processors and r
jstm.tistory.com
2023.12.14 - [Introduce and analyze companies] - What is Pfizer Inc.? - Products and History
What is Pfizer Inc.? - Products and History
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation1. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart1. Pfizer develops and produces medicines an
jstm.tistory.com
'Introduce and analyze companies' 카테고리의 다른 글
| What is Chevron? - Products and History (1) | 2023.12.15 |
|---|---|
| What is The Home Depot? - Products and History (1) | 2023.12.15 |
| What is AMD? - Products and History (1) | 2023.12.14 |
| What is Pfizer Inc.? - Products and History (1) | 2023.12.14 |
| What is Procter & Gamble? - Products and History (2) | 2023.12.13 |
댓글